Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer
Authors:
- 12 January 2018
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 25 (4) , 937-946
Abstract
This study investigated the prognostic value of tumor-infiltrating lymphocyte (TIL) density as determined by molecular subtype and receipt of adjuvant chemotherapy in invasive breast cancer (IBC). StrKeywords
Funding Information
- Medical Research Center Program through the National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future Planning (2015R1A5A2009124)
This publication has 27 references indexed in Scilit:
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199Journal of Clinical Oncology, 2014
- Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patientsAnnals of Oncology, 2014
- Is the Tumor Infiltrating Natural Killer Cell (NK-TILs) Count in Infiltrating Ductal Carcinoma of Breast Prognostically Significant?Asian Pacific Journal of Cancer Prevention, 2014
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialAnnals of Oncology, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- CD4+ follicular helper T cell infiltration predicts breast cancer survivalJournal of Clinical Investigation, 2013
- Leukocyte composition of human breast cancerProceedings of the National Academy of Sciences, 2011
- Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast CancerJournal of Clinical Oncology, 2011
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010